With 203 intellectual property partners and associates in a firm of 903 lawyers, Winston & Strawn’s intellectual property practice is one of the most active in the country. The Chicago-based firm as at the forefront of high-technology, biotechnology, pharmaceutical and new-media industry litigation. George Lombardi in the Chicago office chairs the practice.
Among the cases the firm handled during 2013 were AstraZeneca PLC v. Andrx Pharmaceuticals Inc., a closely watched case in which a trial court granted a motion by Winston & Strawn partner Jim Hurst to exclude AstraZeneca’s theory of damages for infringement of patents related to Prilosec. AstraZeneca had sought more than $140 million.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]